Status:
COMPLETED
Empirical Antibiotic and Outcome in Community-onset Bacteremia
Lead Sponsor:
Phramongkutklao College of Medicine and Hospital
Conditions:
Bacteremia
Eligibility:
All Genders
18+ years
Brief Summary
Empirical antibiotic and outcome in Community-onset Bacteremia Caused by third generation cephalosporin resistant Enterobacteriaceae
Detailed Description
Prospective cohort study is conducted for monitoring outcomes and risk factors among community-onset bacteremia caused by third generation cephalosporin resistant enterobacteriaceae. Primary endpoint...
Eligibility Criteria
Inclusion
- Patient with Community-onset Bacteremia Caused by third generation cephalosporin resistant Enterobacteriaceae. Age \> 18 years
Exclusion
- Pregnancy
- Polymicrobial infection
Key Trial Info
Start Date :
November 22 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT03765749
Start Date
November 22 2018
End Date
December 31 2021
Last Update
April 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Worapong Nasomsong
Bangkok, Thailand, 10400